Starting from 3,6-dichloro-4-pyridazinecarboxylic acid chloride a series of novel pyridazino[3,4-b][1,S]benzoxazepin-S(6H)-ones as 1,2-diazine isosters of nonnucleoside reverse transcriptase inhibitors was prepared via N-(2-hydroxyphenyl)-3,6-dichloro-4-pyridazinecarboxamides. The inhibition of HIV-1 reverse transcriptase was evaluated.
Introduction
Reverse transcriptase (RT) is an essential enzyme for the human immunodeficiency virus (HIV) replication. Two classes of RT-inhibitors are known: nucleoside analogues which interact at the active site of the reverse transcriptase, and non-nucleoside inhibitors (De Clercq, 1995) . The latter interact allosterically with a specific non-substrate binding site ('pocket') of the enzyme (Kohlstaedt et al., 1992; DeClercq, 1994) . Recently, dibenzoxazepinones, dibenzodiazepinones, and related monoand dipyrido derivatives (compounds of type 1 and 2, e.g. nevirapine) have been reported to inhibit HIV-1 reverse Received 20 May, 1996; revised 5 July, 1996; accepted 8 July, 1996. 'For correspondence. Tel. (0043)512507-5250 or -5262; Fax (0043)512 507-2940.
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Although a wide range of structural modifications of compounds of type 1 and 2 have been performed (Adams and Merluzzi, 1993; Boyode et al., 1995; Kelly et al., 1995; Proudfoot et al., 1995) , so far no attempts have been made to prepare and investigate 1,2-diazine congeners. Within a programme aimed at the synthesis of 6,11-dihydropyridazino[3,4-b][1,5]benzodiazepin-5-ones and pyridazino [3,4-b] [1 ,5]benzoxazepin-5(6H)-ones we have tried recently to employ the pyridazine-4-carboxamides 4 or S as precursors for the construction of our target ring systems. Whereas we have found that treatment of 4 with sodium hydride does not afford the expected 6,11-dihydropyridazino[3,4-b][1,5]benzodiazepin-5-one system 6 but results in a novel pyridazine~pyrazole ring contraction reaction (Heinisch et al., 1994) , we have now succeeded in preparing the pyridazino[3,4-b][1,5]benzoxazepin-5(6H)-one system 7. Here we report on the preparation of a series of derivatives of this novel tricycle and on the evaluation of their activity against HIV-1 reverse transcriptase.
Results

Chemistry
The pyridazino[3,4-b][1,5]benzoxazepin-5(6H)-ones 7 were prepared as outlined in Fig. 2 . Reaction of 3,6dichloro-4-pyridazinecarboxylic acid chloride 3 with (substituted) 2-aminophenol(s) in dry dichloromethane afforded the 3,6-dichloro-N (2-hydroxyphenyl) pyridazine-4-carboxamides 5 in satisfactory yields. In contrast to our previous observations with N-(2-aminophenyl)-3,6-dichloropyridazine-4-carboxamide 4 (Heinisch et al., 1994) , we did not meet any problems in converting compounds S into the novel pyridazino[3,4-b][1,5]benzoxazepin-5(6H)-ones 7a-f by treatment with sodium hydride.
In order to find access to N(6)-substituted derivatives, various alkylation conditions (e.g. sodium hydride/ dimethylformamide, potassium tert-butoxidel1 ,4-dioxane, dichloromethane/aqueous sodium hydroxide/ tetrabutylammonium bromide as phase-transfer catalyst) were investigated. The best results were obtained when a solution of the pyridazino[3,4-b][1,5]benzoxazepin-5(6H)-one 7a-f in dry dimethylsulfoxide was treated for 1 h with two equivalents of powdered potassium hydroxide and subsequently with 1.5-2 equivalents of the alkyl halide at room temperature. Reaction with cyclopropylmethylchloride was performed using potassium carbonate and catalytic amounts of sodium iodide in dimethylformamide at 100°C. Whereas most of the chloro substituted derivatives turned out to be only poorly soluble under the conditions required for investigation of RT inhibition, the corresponding dehalogenated compounds in general were found to exhibit sufficient solubility. Transformation of the chloro compounds 7-13 into compounds 14-20 could be achieved smoothly by catalytic transfer hydrogenation employing ammonium formate as the hydrogen source. It should be noted that in the case of the N-allyl substituted compounds the dechlorination has to be done prior to alkylation in order to avoid hydrogenation of the C-C double bond (see Fig. 3 .).
All these new compounds were fully characterized and their structures were assigned on the basis of microanalyses and NMR spectra. In view of the above-mentioned surprising reaction behaviour of 4 in attempted ring closure, an X-ray structure analysis of a representative derivative, i.e. 9d (R =9-CH s , R' = CH 2Ph, R" = CI) (see Table 10 ), was also performed in order to ensure the pyridazino[3,4-b][1 ,5]benzoxazepin-5(6H)-one structure.
Virology
The newly synthesized compounds of types 7-20, except those which were found not to be sufficiently soluble, were tested in vitro for inhibition of reverse transcriptase. In general, concentrations of up to 330 !-1M were used. The results obtained are summarized in In general, the replacement of the benzene moiety in the salicyclic acid substructure of compounds of type 1 by a 1,2-diazine system was found to result in a decrease of activity. From in-vitro investigations of the potential of compounds 7-20 as reverse transcriptase inhibitors the following structure-activity relationships could be established: those compounds with a chiaro substituent in position 3 which could be tested due to sufficient solubility exhibit potencies lower than those of the corresponding unsubstituted analogues (e.g. 10b/17b, 10d/17d, 10f/17f, 12e/1ge, 13f/20f). Substitution in the benzene part of the molecule has a profound effect on activity: derivatives with methyl or methoxy substituents attached to the carbocyclic moiety are more potent than the corresponding unsubstituted compounds. Maximum enzyme inhibition in our series is obtained with 8-methyl or 8,10dimethyl derivatives. A decrease of activity occurs when the 8-methyl group is replaced by trifluoromethyl. This effect has also been described for nevi rapine and its fluorinated derivative (Boyode et al., 1995) . At N-6 lipophilic substituents of intermediate size such as n-propyl, ipropyl, cyclopropylmethyl, i-butyl, or allyl (e.g. 17c, 17f, 17 k, 17 I, 20b, 20c, 20f and 20 g) are beneficial. This finding is in accordance with the results in the dibenzand pyridobenzoxazepinone series (Klunder et al., 1992) .
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Materials and Experimental Procedures: Chemistry
Melting points were determined on a Kofler hot-stage microscope (Reichert) and are uncorrected. Infrared spectra were recorded on a Mattson Galaxy Series FTIR 3000 spectrophotometer from KBr pellets. 1H and 1SC NMR spectra were recorded on a Varian Gemini 200 spectrometer CH: 199.98 MHz, 1SC: 50.29 MHz). The centre of the solvent multiplet was used as internalstandard (chemicalshifts in 8 p.p.m.), which was related to TMS with 82.49 p.p.m. for 1H and 839.5 p.p.m. for 1SC (DMSO-d s ) or with 87.26 p.p.m. for 1H and 8 77.0 p.p.m. for 1SC (CDCl s ). Elemental analyses were performed by Mag. J. Theiner, Institute of Physical Chemistry, University of Vienna, Austria. All analyses were within 0.3% of the calculatedvalues. Reactionswere monitoredby TLC using Polyqrarn'" SIL G/UV 2 5 4 (Macherey-Nagel) plastic-backed plates (0.25 mm layer thickness). Light petroleum refers to the fraction of bp 40-60°C.
Starting materials
3,6-Dichloropyridazine-4-carboxylic acid chloride 3 was prepared from 3,6-dichloro-4-pyridazinecarboxylic acid with SOCI 2 (Ried and Eichhorn, 1988); 3,6-dichloropyridazine-4-carboxylic acid was available from 3,6-dichloro-4-methylpyridazine via oxidationwith K 2Cr2 0 7 (Heinisch, 1973) .
General procedure for the preparation of 5a-f
To an ice-cooled solution of the appropriate 2-aminophenol derivative (10.3 mmol) and triethylamine (1.619 g, 16.0 mmol) in dry dichloromethane (50 mL) was added dropwise a solution of 3,6-dichloropyridazine-4-carboxylic acid chloride3 (2.114 g, 10.0 mmol) in dry dichloromethane (20 mL) under a nitrogen atmosphere. The mixturewas then stirred at room temperature for 1 h. After dilution with dichloromethane, the solution was washed with 1 Nhydrochloric acid. The resulting crystals were filtered off and washed with dichloromethane and water. The organic layer was washed with 1 N HCI (twice), water and brine, dried over anhydrous sodium sulphate, and evaporated in vacuo.
The crude products could be used in the following reaction step. Analytically pure samples were obtained by recrystallization. For recrystallization solvents, yields and physicaldata see Tables 2 and 3 .
General procedure for the preparation of 3-
Sodium hydride (0.240 g of a 60% dispersion in oil, 6.0 mmol) was added at room temperature to a solution of 5 (2 mmol) in 50 mL of dry 1A-dioxane under a nitrogen atmosphere. The reaction mixture was refluxed until the starting material was completely consumed (TLC monitoring, diethyl ether, approx. 15 min). After cooling to room temperature, the solution was poured under a nitrogen atmosphere into cold 0.5 N HCI (200 mL), the resulting crystals were collected, washed with water and subsequently with light petroleum. The products thus obtained were used without a R' No.
5a further purification in the following reaction step. Analytically pure material was obtained by recrystallization. For recrystallization solvents, yields and physical data see Tables 4  and 5 .
General procedure for the N(6)-alkylation powdered potassium hydroxide (0.224 g, 4.0 mmol, 2 equiv.) was added at room temperature to a solution of 2 mmol of 7, or 14 in dry dimethyl sulfoxide (15 mL) under a nitrogen atmosphere. After stirring for 1 h at room temperature, the appropriate alkyl iodide (2.2-3.0 mmol) or benzyl bromide (2.2 mmol) was added and the stirring was continued until the starting material was completely alkylated (TLC monitoring, diethyl ether, approx. 30-120 min). If necessary, another equivalent of the alkylating agent was added and the reaction mixture was stirred for a further 60 min.Then the mixture was poured into cold 0.5 N HCI (150 mL) and the resulting crystals were collected, washed with water and subsequently with light petroleum. If the product did not crystallize, the mixture was extracted with dichloromethane. The organic phase was washed with water and brine, dried over anhydrous sodium sulphate and evaporated. The products were purified by column chromatography and/or recrystallization. For yields, eluents, recrystallization solvents and physical data see Tables 6-9 . The structure was solved with direct methods and refined by full-matrix least-squares using program SHELX76 (Sheldrick, 1976) 
Crystal structure determination of C19H14CINs02 9d
anisotropic temperature factors for non-hydrogen atoms, and a correction for extinction. All hydrogen atoms were located from a difference Fourier map and were refined in positional parameters and isotropic temperature factors. The hydrogens of the methyl group, which was found to show orientational disorder, were refined as parts of a rigid Pyridazino[3,4-b][1,5]benzoxazepin-5(6H)-ones 307 group (C-H = 0.96 A) with two sets of approximately halfoccupied hydrogen atoms and one common isotropic temperature factor. Final refinement on F gave R = 0.033, wR = 0.037, and S = 1.88 for 2337 reflections and 276 parameters. Maximum and minimum residual electron densities were 0.16 and -0.25 e k S .
Atomic coordinates of non-hydrogen atoms are given in Table 10 . A view of the molecule and salient bond lengths is presented in Fig. 4 . Bond lengths and angles are in good accord with literature values. The tricyclic core of the molecule is folded asymmetrically about the C(6)-N(7)-O(14) plane. The pyridazine ring and the methylbenzene ring make angles of 17.6(1)°and 43.4(1 t with this plane, whereas the angle between them is 61.0(1)°. These conformational characteristics of the tricyclic core of 9d agree with those of other dibenzo-heteroepine compounds. An example with a very similar seven-membered ring is nitroxazepine chloride monohydrate (Usha et el., 1982) . The bond lengths in the sevenmembered rings of 9d and this compound differ on average by only 0.011 A.
Further details of the crystal structure investigation are available from the Fachinformationszentrum Karlsruhe, 0-76344 Eggenstein-Leopoldshafen (Germany), on quoting the depository number CSO-405254.
General procedure for the preparation of 14 and 15-20 by reductive dehalogenation A mixture of 7 or 8-13 (1.2 mmol) ammonium formate (0.378 g, 6.0 mmol, 5 equiv.) and 0.114 g of Pd/C (10%) in 20 mL of methanol was stirred under a nitrogen atmosphere at 48°C for 30 min. The catalyst was filtered off, the solvent was removed in vacuo, and the residue was taken up in dichloromethane. This solution was washed with water and brine, dried over anhydrous sodium sulphate and evaporated. The products thus obtained were purified by column chromatographyand/or recrystallization from suitable solvents. For yields, eluents, recrystallization solvents and physical data see Tables 11 and 12 .
Supplementary material
Further NMR data are available from the Editor-in-Chief; the request must be accompanied by the full journal reference.
Materials and Experimental Procedures: Biology
HIV-1 reverse transcriptase inhibition
The measurement of in-vitro HIV-1 reverse transcriptase inhibition was performed with the non-radioactive RT-Kit from Boehringer Mannheim. For exact composition and concentration of the solutions and for precise working procedure see instructions of the assay (Cat. no. 1468 120).
The compounds were dissolved in DMSO (20 mmol L-1) and further diluted with lysis buffer (5 IJLof the DMSO solution and 95 IJLof lysis buffer = solution 1; 10 IJLof solution 1 and 90 IJL of lysis buffer = solution 2) shortly before use.
Test compounds: 5 IJL of RT dilution (5 ng well'), 15 IJL of lysis buffer, 20 IJLof a solution of the compound (1-0.01 mmol L-1 in DMSO/lysis buffer), and 20 IJL of reaction mixture (template and nucleotides) were incubated for 1 h at 37°C.
RT standards: 5 IJLof RT dilution (1,2 or 5 ng welr', respectively), 35 IJLof lysis buffer, and 20 IJLof reaction mixture (template and nucleotides) were incubated for 1 h at 37°C.
Blank value: 40 IJLof lysis buffer and 20 IJLof reaction mix-ture (template and nucleotides) were incubated for 1 h at 3rC.
Then the reaction solutions were transferred into the streptavidin-coated microplate modules and incubated for 1 h at 37°C. The samples were discarded and plates were washed five times with washing buffer. After washing, 200 IJL of anti DIG-peroxidase conjugate (200 mU mL-1) was added to each well and the re~uiting mixtures were incubated for 1 h at 3rC. After additional washing (see above), 200 IJL of POD substrate (2,2"-azinobis-3-ethylbenzothiazoline-6-sulfonate) were added to each well and the mixture was incubated at room temperature (10-15 min). The absorbance of the samples was measured at 405 nm with a reference wavelength at 490 nm using a microtitre plate (ELISA) reader.
